Testing an implementation strategy to help primary care providers provide mental health medications for veterans with PTSD (PROMPT trial)

Promoting Evidence-Based Pharmacotherapy for PTSD in Community Based Outpatient Clinics

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16140131

Enrollment

363

Registered

2019-03-06

Start date

2012-03-01

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prescribing medications for Posttraumatic Stress Disorder (PTSD) Mental and Behavioural Disorders

Interventions

We tested whether an implementation intervention (i.e., optional free CME training in guideline-recommended PTSD pharmacotherapy, point-of-care provider decision support tool availability, and externa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: sites where leadership agreed to study participation

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
Change in the proportion of patients in providers' panels who received a PTSD guideline-recommended medication (either a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI)) from the year pre-intervention relative to the year post-intervention, measured using patient notes.	—

Secondary

Measure	Time frame
Subgroup analyses comparing prescribing behavior between training participants and non-participants at the intervention sites.	—

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026